The risk of death at 1 year after PCI in relation to stent inflation pressure (panel A).

<p>Estimated cumulative event rates of death in relation to stent inflation pressure (panel B).</p

The risk of restenosis at 1 year after PCI in relation to stent inflation pressure (panel A).

<p>Estimated cumulative event rates of restenosis in relation to stent inflation pressure (panel B).</p

Baseline characteristics of the biochemical parameters of 7 subadult brown bears in Sweden in 2010 during hibernation in the winter and the active state in the summer and comparisons of hibernation and active state values.

<p>Figures are mean±SEM.</p><p>Comparisons are made by the Wilcoxon test for paired samples.</p

Pearson's correlation coefficient between parameters of bone turnover and calcitropic hormones of 7 subadult bears in Sweden in 2010 during hibernation in winter and the active state in the summer.

a<p>p = 0.08, *Significant correlation, i.e. p<0.05.</p

Estimated cumulative event rates of stent thrombosis in relation to post-dilatation (panel A).

<p>The RR of stent thrombosis of 1.18 (CI 0.95–1.32) did not differ statistically between procedures with or without post-dilatation (P = 0.19). Estimated cumulative event rates of restenosis in relation to post-dilatation (panel B). Restenosis occurred more often following post-dilatation compared with procedures where this adjunct was not used (RR 1.22 (CI 1.14–1.32) P<0.001). Estimated cumulative event rates of death in relation to post-dilatation (Panel C). The risk of death was lower following post-dilatation (RR 0.81 (CI 0.71–0.93) P = 0.003). The numbers at risk are for stent thrombosis and restenosis are identical to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0056348#pone-0056348-g001" target="_blank">Figure 1</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0056348#pone-0056348-g002" target="_blank">2</a> while the numbers at risk for death are identical to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0056348#pone-0056348-g003" target="_blank">Figure 3</a>.</p

Characteristics of the patient cohort with CD and follow-up biopsies.

<p>(Excludes patients with a diagnosis of IHD prior to follow-up biopsy, n = 208).</p><p>CD, celiac disease</p><p>IHD. Ischemic heart disease</p><p>MI, Myocardial infarction</p><p>*The sum of IHD subtypes is greater than the total number of patients with IHD because of patients who had more than one type of IHD event</p><p>†Among patients without a history of AF at the time of follow-up biopsy (n = 7,530).</p><p>Characteristics of the patient cohort with CD and follow-up biopsies.</p

Association of persistent villous atrophy with IHD overall, and stratified by time after follow-up biopsy.

<p>HR, Hazard Ratio</p><p>†Adjusted for patient age at follow-up biopsy, gender, calendar period of follow-up biopsy, education, and duration of celiac disease at the time of follow-up biopsy</p><p>Association of persistent villous atrophy with IHD overall, and stratified by time after follow-up biopsy.</p

Association of persistent villous atrophy with IHD, stratified by gender, age, and year of CD diagnosis.

<p>HR, Hazard ratio</p><p>IHD. Ischemic heart disease</p><p>†Adjusted for patient age at follow-up biopsy, gender, calendar period of follow-up biopsy, education, and duration of celiac disease at the time of follow-up biopsy.</p><p>Association of persistent villous atrophy with IHD, stratified by gender, age, and year of CD diagnosis.</p

Risk of IHD type (myocardial infarction, stable angina, and unstable angina), and risk of death due to IHD in patients with CD who have persistent villous atrophy on follow-up biopsy, compared to those with mucosal healing.

<p>CD, celiac disease</p><p>HR, Hazard ratio</p><p>IHD. Ischemic heart disease</p><p>MI, Myocardial infarction</p><p>†Adjusted for patient age at follow-up biopsy, gender, calendar period of follow-up biopsy, education, and duration of celiac disease at the time of follow-up biopsy</p><p>Risk of IHD type (myocardial infarction, stable angina, and unstable angina), and risk of death due to IHD in patients with CD who have persistent villous atrophy on follow-up biopsy, compared to those with mucosal healing.</p

Risk of atrial fibrillation in patients with CD according to follow-up histology.

<p>CD, celiac disease; HR, Hazard ratio; NC Not calculated.</p><p>†Adjusted for patient age at follow-up biopsy, gender, calendar period of follow-up biopsy, education, and duration of celiac disease at the time of follow-up biopsy</p><p>Risk of atrial fibrillation in patients with CD according to follow-up histology.</p